AlphaYouFM
Schedule 13G filing
FMR LLC disclosed a 10.2% stake in Eikon Therapeutics, Inc. (EIKN)
FMR LLC reported owning 10.2% of Eikon Therapeutics, Inc. (EIKN) (5,520,152 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G
More EIKN insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.